The DOI matches its Crossref record, with a small difference in title or year; 130 of the 130 references it cites were found in a registry or an index.
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis
Open accessAbstract
IMPORTANCE: Neurofilament light protein (NfL) is elevated in cerebrospinal fluid (CSF) of a number of neurological conditions compared with healthy controls (HC) and is a candidate biomarker for neuroaxonal damage. The influence of age and sex is largely unknown, and levels across neurological disorders have not been compared systematically to date. OBJECTIVES: To assess the associations of age, sex, and diagnosis with NfL in CSF (cNfL) and to evaluate its potential in discriminating clinically similar conditions. DATA SOURCES: PubMed was searched for studies published between January 1, 2006, and January 1, 2016, reporting cNfL levels (using the search terms neurofilament light and cerebrospinal fluid) in neurological or psychiatric conditions and/or in HC. STUDY SELECTION: Studies reporting NfL levels measured in lumbar CSF using a commercially available immunoassay, as well as age and sex. DATA EXTRACTION AND SYNTHESIS: Individual-level data were requested from study authors. Generalized linear mixed-effects models were used to estimate the fixed effects of age, sex, and diagnosis on log-transformed NfL levels, with cohort of origin modeled as a random intercept. MAIN OUTCOME AND MEASURE: The cNfL levels adjusted for age and sex across diagnoses. RESULTS: Data were collected for 10 059 individuals (mean [SD] age, 59.7 [18.8] years; 54.1% female). Thirty-five diagnoses were identified, including inflammatory diseases of the central nervous system (n = 2795), dementias and predementia stages (n = 4284), parkinsonian disorders (n = 984), and HC (n = 1332). The cNfL was elevated compared with HC in a majority of neurological conditions studied. Highest levels were observed in cognitively impaired HIV-positive individuals (iHIV), amyotrophic lateral sclerosis, frontotemporal dementia (FTD), and Huntington disease. In 33.3% of diagnoses, including HC, multiple sclerosis, Alzheimer disease (AD), and Parkinson disease (PD), cNfL was higher in men than women. The cNfL increased with age in HC and a majority of neurological conditions, although the association was strongest in HC. The cNfL overlapped in most clinically similar diagnoses except for FTD and iHIV, which segregated from other dementias, and PD, which segregated from atypical parkinsonian syndromes. CONCLUSIONS AND RELEVANCE: These data support the use of cNfL as a biomarker of neuroaxonal damage and indicate that age-specific and sex-specific (and in some cases disease-specific) reference values may be needed. The cNfL has potential to assist the differentiation of FTD from AD and PD from atypical parkinsonian syndromes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies
Whiting, P. F., Rutjes, A. W. S., Westwood, M. E., Mallett, S., Deeks, J. J., Reitsma, J. B., Leeflang, M. M. G., Sterne, J. A. C., Bossuyt, P. M. M., & the QUADAS-2 Group* (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-8-201110180-00009 · Cited by 14,199
Hughes, A. J., Daniel, S. E., Kilford, L., & Lees, A. J. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.3.181 · Cited by 10,378
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria
Polman, C. H., Reingold, S. C., Banwell, B., Clanet, M., Cohen, J. A., Filippi, M., Fujihara, K., Havrdova, E., Hutchinson, M., Kappos, L., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22366 · Cited by 9,802
Self-citationMcDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H., Lublin, F. D., McFarland, H. F., Paty, D. W., Polman, C. H., Reingold, S. C., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1032 · Cited by 6,969
Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria
Neary, D., Snowden, J. S., Gustafson, L., Passant, U., Stuss, D., Black, S., Freedman, M., Kertesz, A., Robert, P. H., Albert, M., et al. (1998) · Neurology · doi:10.1212/wnl.51.6.1546 · Cited by 5,047
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
Polman, C. H., Reingold, S. C., Edan, G., Filippi, M., Hartung, H., Kappos, L., Lublin, F. D., Metz, L. M., McFarland, H. F., O'Connor, P. W., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20703 · Cited by 5,017
Self-citationDiagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium
McKeith, I. G., Boeve, B. F., Dickson, D. W., Halliday, G., Taylor, J.-P., Weintraub, D., Aarsland, D., Galvin, J., Attems, J., Ballard, C. G., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004058 · Cited by 4,476
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Dubois, B., Feldman, H. H., Jacova, C., Hampel, H., Molinuevo, J. L., Blennow, K., DeKosky, S. T., Gauthier, S., Selkoe, D., Bateman, R., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70090-0 · Cited by 3,321
Self-citationSocioeconomic Inequalities in Health in 22 European Countries
Mackenbach, J. P., Stirbu, I., Roskam, A.-J. R., Schaap, M. M., Menvielle, G., Leinsalu, M., & Kunst, A. E. (2008) · New England Journal of Medicine · doi:10.1056/nejmsa0707519 · Cited by 3,289
Clinical diagnostic criteria for dementia associated with Parkinson’s disease
Emre, M., Aarsland, D., Brown, R., Burn, D. J., Duyckaerts, C., Mizuno, Y., Broe, G. A., Cummings, J., Dickson, D. W., Gauthier, S., et al. (2007) · Movement Disorders · doi:10.1002/mds.21507 · Cited by 3,027
Diagnostic Criteria for Parkinson Disease
Gelb, D. J., Oliver, E., & Gilman, S. (1999) · Archives of Neurology · doi:10.1001/archneur.56.1.33 · Cited by 2,822
Aune, D., Giovannucci, E., Boffetta, P., Fadnes, L. T., Keum, N., Norat, T., Greenwood, D. C., Riboli, E., Vatten, L. J., & Tonstad, S. (2017) · International Journal of Epidemiology · doi:10.1093/ije/dyw319 · Cited by 2,419
Critical review: vegetables and fruit in the prevention of chronic diseases
Boeing, H., Bechthold, A., Bub, A., Ellinger, S., Haller, D., Kroke, A., Leschik‐Bonnet, E., Müller, M. J., Oberritter, H., Schulze, M. B., et al. (2012) · European Journal of Nutrition · doi:10.1007/s00394-012-0380-y · Cited by 1,875
Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups.
(1994) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.57.4.416 · Cited by 1,331
Consensus statement on the diagnosis of multiple system atrophy
Gilman, S., Low, P. A., Quinn, N. P., Albanese, A., Ben‐Shlomo, Y., Fowler, C. J., Kaufmann, H., Klockgether, T., Lang, A. E., Lantos, P. L., et al. (1998) · Clinical Autonomic Research · doi:10.1007/bf02309628 · Cited by 1,323
The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service
Hughes, A. J., Daniel, S. E., Ben‐Shlomo, Y., & Lees, A. J. (2002) · Brain · doi:10.1093/brain/awf080 · Cited by 1,258
Diagnosing Idiopathic Normal-pressure Hydrocephalus
Relkin, N. R., Marmarou, A., Klinge, P. M., Bergsneider, M., & Black, P. M. (2005) · Neurosurgery · doi:10.1227/01.neu.0000168185.29659.c5 · Cited by 1,240
Fruit and vegetable consumption and stroke: meta-analysis of cohort studies
He, F. J., Nowson, C. A., & MacGregor, G. A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68069-0 · Cited by 1,108
Consensus statement on the diagnosis of multiple system atrophy
Gilman, S., Low, P. A., Quinn, N. P., Albanese, A., Ben‐Shlomo, Y., Fowler, C. J., Kaufmann, H., Klockgether, T., Lang, A. E., Lantos, P. L., et al. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00304-9 · Cited by 918
de Irala, J., Groth, M., Johansson, L., Oltersdorf, U., Prättälä, R., & Martínez‐González, M. Á. (2000) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601080 · Cited by 682
Mackenbach, J. P., Kulhánová, I., Bopp, M., Deboosere, P., Eikemo, T. A., Hoffmann, R., Kulik, M. C., Leinsalu, M., Martikainen, P., Menvielle, G., et al. (2014) · Social Science & Medicine · doi:10.1016/j.socscimed.2014.05.021 · Cited by 590
Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis
Lu, C.-H., Macdonald-Wallis, C., Gray, E., Pearce, N., Petzold, A., Norgren, N., Giovannoni, G., Fratta, P., Sidle, K., Fish, M., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001642 · Cited by 563
Self-citationThe Journal of Comparative Neurology
Wistar Institute of Anatomy and Biology. (2006) · The Journal of Comparative Neurology · doi:10.1002/(issn)1096-9861 · Cited by 536
Ashwal, S., Bale, J. F., Coulter, D. L., Eiben, R., & Garg, B. P. (2006) · Annals of Neurology · doi:10.1002/(issn)1531-8249 · Cited by 514
Rosengren, L. E., Karlsson, J., Karlsson, J., Persson, L. I., & Wikkelsø, C. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67052013.x · Cited by 499
Self-citationIncreased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases
Gaiottino, J., Norgren, N., Dobson, R., Topping, J. H., Nissim, A., Malaspina, A., Bestwick, J. P., Monsch, A. U., Regeniter, A., Lindberg, R. L. P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075091 · Cited by 493
Self-citationZetterberg, H., Skillbäck, T., Mattsson, N., Trojanowski, J. Q., Portelius, E., Shaw, L. M., Weiner, M. W., Blennow, K., & Initiative, F. T. A. D. N. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2015.3037 · Cited by 487
Self-citationEvidence of early cortical atrophy in MS
Stefano, N. D., Matthews, P. M., Filippi, M., Agosta, F., Luca, M. D., Bartolozzi, M. L., Guidi, L., Ghezzi, A., Montanari, E., Cifelli, A., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000055926.69643.03 · Cited by 482
A revision of the El Escorial criteria - 2015
Ludolph, A. C., Drory, V. E., Hardiman, O. M., Nakano, I., Ravits, J., Robberecht, W., Shefner, J. M., & for The WFN Research Group On ALS/MND (2015) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2015.1049183 · Cited by 477
Hall, S., Öhrfelt, A., Constantinescu, R., Andreasson, U., Surova, Y., Bostrom, F., Nilsson, C., Widner, H., Decraemer, H., Nägga, K., et al. (2012) · Archives of Neurology · doi:10.1001/archneurol.2012.1654 · Cited by 473
Self-citationClinicopathological correlations in corticobasal degeneration
Lee, S. E., Rabinovici, G. D., Mayo, M. C., Wilson, S. M., Seeley, W. W., DeArmond, S. J., Huang, E. J., Trojanowski, J. Q., Growdon, M. E., Jang, J. Y., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22424 · Cited by 434
Self-citationMcGill, R., Anwar, E., Orton, L., Bromley, H., Lloyd-Williams, F., O’Flaherty, M., Taylor-Robinson, D., Guzman-Castillo, M., Gillespie, D., Moreira, P., et al. (2015) · BMC Public Health · doi:10.1186/s12889-015-1781-7 · Cited by 407
Mäki, N., Martikainen, P., Eikemo, T. A., Menvielle, G., Lundberg, O., Östergren, O., Jasilionis, D., & Mackenbach, J. P. (2013) · Social Science & Medicine · doi:10.1016/j.socscimed.2013.06.009 · Cited by 358
Genkinger, J. M., Platz, E. A., Hoffman, S. C., Comstock, G. W., & Helzlsouer, K. J. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh339 · Cited by 351
Litvan, I., Agid, Y., Jankovic, J. J., Goetz, C. G., Brandel, J., Lai, E. C., Wenning, G. K., D'Olhaberriague, L., Verny, M., Chaudhuri, К. R., et al. (1996) · Neurology · doi:10.1212/wnl.46.4.922 · Cited by 347
Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab
Gunnarsson, M., Malmeström, C., Axelsson, M., Sundström, P., Dahle, C., Vrethem, M., Olsson, T. P., Piehl, F., Norgren, N., Rosengren, L., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22247 · Cited by 346
Self-citationNeurofilament light protein and glial fibrillary acidic protein as biological markers in MS
Malmeström, C., Haghighi, S., Rosengren, L., Andersen, O., & Lycke, J. (2003) · Neurology · doi:10.1212/01.wnl.0000098880.19793.b6 · Cited by 318
Self-citationAssessing the validity of the Global Activity Limitation Indicator in fourteen European countries
Berger, N., Oyen, H. J. V., Cambois, E., Fouweather, T., Jagger, C., Nusselder, W. J., & Robine, J. (2015) · BMC Medical Research Methodology · doi:10.1186/1471-2288-15-1 · Cited by 317
Fruit and vegetable consumption and the risk of depression: A meta-analysis
Liu, X., Yan, Y., Li, F., & Zhang, D. (2015) · Nutrition · doi:10.1016/j.nut.2015.09.009 · Cited by 287
Inflammation, demyelination, and degeneration — Recent insights from MS pathology
Stadelmann, C., Wegner, C., & Brück, W. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.07.007 · Cited by 276
Wild, E. J., Boggio, R., Langbehn, D. R., Robertson, N., Salman, H., Miller, J. R. C., Zetterberg, H., Leavitt, B. R., Kuhn, R. R., Tabrizi, S. J., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80743 · Cited by 265
Self-citationCSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival
Skillbäck, T., Farahmand, B., Bartlett, J. W., Rosén, C., Mattsson, N., Nägga, K., Kilander, L., Religa, D., Wimo, A., Winblad, B., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000001015 · Cited by 263
Self-citationNeurofilament light chain: a biomarker for genetic frontotemporal dementia
Meeter, L. H., Dopper, E. G., Jiskoot, L. C., Sanchez‐Valle, R., Graff, C., Benussi, L., Ghidoni, R., Pijnenburg, Y. A., Borroni, B., Galimberti, D., et al. (2016) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.325 · Cited by 263
Self-citationJagger, C., Gillies, C., Cambois, E., Oyen, H. J. V., Nusselder, W. J., & Robine, J. (2010) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.11.002 · Cited by 258
Magdalinou, N. K., Paterson, R. W., Schott, J. M., Fox, N. C., Mummery, C. J., Blennow, K., Bhatia, K. P., Morris, H. R., Giunti, P., Warner, T. T., et al. (2015) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-309562 · Cited by 254
Self-citationScherling, C. S., Hall, T., Berisha, F., Klepac, K., Karydas, A., Coppola, G., Kramer, J. H., Rabinovici, G., Ahlijanian, M., Miller, B. L., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24052 · Cited by 249
Self-citationNeurofilament and glial fibrillary acidic protein in multiple sclerosis
Norgren, N., Sundström, P., Svenningsson, A., Rosengren, L., Stigbrand, T. I., & Gunnarsson, M. (2004) · Neurology · doi:10.1212/01.wnl.0000142988.49341.d1 · Cited by 242
Self-citationPohjasvaara, T., Mäntylä, R., Ylikoski, R., Kaste, M., & Erkinjuntti, T. (2000) · Stroke · doi:10.1161/01.str.31.12.2952 · Cited by 238
CSF biomarkers and clinical progression of Parkinson disease
Hall, S., Surova, Y., Öhrfelt, A., Zetterberg, H., Lindqvist, D., & Hansson, O. (2014) · Neurology · doi:10.1212/wnl.0000000000001098 · Cited by 236
Self-citationNeurofilaments as biomarkers in multiple sclerosis
Teunissen, C. E., & Khalil, M. (2012) · Multiple Sclerosis Journal · doi:10.1177/1352458512443092 · Cited by 236
Self-citationMackenbach, J. P., Kulhánová, I., Bopp, M., Borrell, C., Deboosere, P., Kovács, K., Looman, C. W. N., Leinsalu, M., Mäkelä, P., Martikainen, P., et al. (2015) · PLoS Medicine · doi:10.1371/journal.pmed.1001909 · Cited by 235
Cohen, J. A., Reingold, S. C., Polman, C. H., & Wolinsky, J. S. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70059-5 · Cited by 233
Erkinjuntti, T., Haltia, M., Palo, J., Sulkava, R. O., & Paetau, A. E. (1988) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.8.1037 · Cited by 229
Cerebrospinal Fluid Patterns and the Risk of Future Dementia in Early, Incident Parkinson Disease
Bäckström, D. C., Domellöf, M. E., Linder, J., Olsson, B., Öhrfelt, A., Trupp, M., Zetterberg, H., Blennow, K., & Forsgren, L. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2015.1449 · Cited by 200
Self-citationDiagnostic criteria for corticobasal syndrome: a comparative study
Mathew, R., Bak, T. H., & Hodges, J. R. (2011) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-300875 · Cited by 200
Idiopathic normal-pressure hydrocephalus
Jeppsson, A., Zetterberg, H., Blennow, K., & Wikkelsø, C. (2013) · Neurology · doi:10.1212/wnl.0b013e31828c2fda · Cited by 183
Self-citationBjerke, M., Zetterberg, H., Edman, Å., Blennow, K., Wallin, A., & Andreasson, U. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-110566 · Cited by 180
Self-citationFingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis
Kühle, J., Disanto, G., Lorscheider, J., Stites, T. E., Chen, Y., Dahlke, F., Francis, G., Shrinivasan, A., Radue, E. W., Giovannoni, G., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001491 · Cited by 176
Self-citationBiomarker Evidence of Axonal Injury in Neuroasymptomatic HIV-1 Patients
Jessen Krut, J., Mellberg, T., Price, R. W., Hagberg, L., Fuchs, D., Rosengren, L., Nilsson, S., Zetterberg, H., & Gisslén, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088591 · Cited by 167
Self-citationGlial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis
Mañé-Martínez, M. A., Olsson, B., Bau, L., Matas, E., Cobo‐Calvo, Á., Andréasson, U., Blennow, K., Romero-Pinel, L., Martínez‐Yélamos, S., & Zetterberg, H. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458514549397 · Cited by 166
Self-citationNeurofilament light in CSF and serum is a sensitive marker for axonal white matter injury in MS
Bergman, J., Dring, A. M., Zetterberg, H., Blennow, K., Norgren, N., Gilthorpe, J. D., Bergenheim, T. A., & Svenningsson, A. (2016) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000271 · Cited by 166
Self-citationFruit and Vegetable Consumption and Mortality
Leenders, M., Sluijs, I., Ros, M. M., Boshuizen, H. C., Siersema, P. D., Ferrari, P., Weikert, C., Tjønneland, A., Olsen, A., Boutron-Ruault, M.-C., et al. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kwt006 · Cited by 163
Yilmaz, A., Blennow, K., Hagberg, L., Nilsson, S., Price, R. W., Schouten, J., Spudich, S., Underwood, J., Zetterberg, H., & Gisslén, M. (2017) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2017.1341313 · Cited by 159
Self-citationFruit and vegetable consumption and all-cause mortality: a dose-response analysis
Bellavia, A., Larsson, S. C., Bottai, M., Wolk, A., & Orsini, N. (2013) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.056119 · Cited by 158
A comparative study of CSF neurofilament light and heavy chain protein in MS
Kuhle, J., Plattner, K., Bestwick, J. P., Lindberg, R. L., Ramagopalan, S. V., Norgren, N., Nissim, A., Malaspina, A., Leppert, D., Giovannoni, G., et al. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458513482374 · Cited by 155
Self-citationUnhealthy behaviours and disability in older adults: Three-City Dijon cohort study
Artaud, F., Dugravot, A., Sabia, S., Singh‐Manoux, A., Tzourio, C., & Elbaz, A. (2013) · BMJ · doi:10.1136/bmj.f4240 · Cited by 154
Tortelli, R., Ruggieri, M., Cortese, R., D’Errico, E., Capozzo, R., Leo, A., Mastrapasqua, M., Zoccolella, S., Leante, R., Livrea, P., et al. (2012) · European Journal of Neurology · doi:10.1111/j.1468-1331.2012.03777.x · Cited by 151
Self-citationCSF neurofilament light chain reflects corticospinal tract degeneration in ALS
Menke, R., Gray, E., Lu, C., Kühle, J., Talbot, K., Malaspina, A., & Turner, M. R. (2015) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.212 · Cited by 141
Self-citationVågberg, M., Norgren, N., Dring, A. M., Lindqvist, T., Birgander, R., Zetterberg, H., & Svenningsson, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135886 · Cited by 141
Self-citationFrank, S., Wilson, R. M., Holloway, R. G., Zimmerman, C. F., Peterson, D. R., Kieburtz, K. D., & Kim, S. Y. H. (2006) · Movement Disorders · doi:10.1002/(issn)1531-8257 · Cited by 131
Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosis
Axelsson, M., Malmeström, C., Gunnarsson, M., Zetterberg, H., Sundström, P., Lycke, J., & Svenningsson, A. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458513490544 · Cited by 128
Self-citationChristensen, J. R., Ratzer, R. L., Börnsen, L. S., Lyksborg, M., Garde, E., Dyrby, T. B., Siebner, H. R., Sørensen, P. S., & Sellebjerg, F. T. (2014) · Neurology · doi:10.1212/wnl.0000000000000361 · Cited by 127
Self-citationOyen, H. J. V., Bogaert, P., Yokota, R. T. C., & Berger, N. (2018) · Archives of Public Health · doi:10.1186/s13690-018-0270-8 · Cited by 126
CSF sAPPβ, YKL-40, and neurofilament light in frontotemporal lobar degeneration
Alcolea, D., Vilaplana, E., Suárez-Calvet, M., Illán-Gala, I., Blesa, R., Clarimón, J., Lladó, A., Sánchez-Valle, R., Molinuevo, J. L., García-Ribas, G., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004088 · Cited by 123
Modvig, S., Degn, M., Roed, H., Sørensen, T., Larsson, H. B. W., Langkilde, A., Frederiksen, J. L., & Sellebjerg, F. T. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458515574148 · Cited by 122
Self-citationCerebrospinal Fluid Biomarker and Brain Biopsy Findings in Idiopathic Normal Pressure Hydrocephalus
Pyykkö, O. T., Lumela, M., Rummukainen, J. K., Nerg, O., Seppälä, T. T., Herukka, S., Koivisto, A. M., Alafuzoff, I. I., Puli, L., Savolainen, S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091974 · Cited by 114
Self-citationNeurofilament ELISA validation
Petzold, A., Altintas, A., Andreoni, L., Bartos, A., Berthele, A., Blankenstein, M. A., Buee, L., Castellazzi, M., Cepok, S., Comabella, M., et al. (2010) · Journal of Immunological Methods · doi:10.1016/j.jim.2009.09.014 · Cited by 105
Self-citationTeunissen, C. E., Elias, N., Koel‐Simmelink, M. J. A., Durieux‐Lu, S., Malekzadeh, A., Pham, T. V., Piersma, S. R., Beccari, T., Meeter, L. H. H., Dopper, E. G. P., et al. (2016) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2015.12.004 · Cited by 103
Self-citationNguyen, B., Bauman, A. E., Gale, J., Banks, E., Kritharides, L., & Ding, D. (2016) · International Journal of Behavioral Nutrition and Physical Activity · doi:10.1186/s12966-016-0334-5 · Cited by 96
Neuronal and Glia-Related Biomarkers in Cerebrospinal Fluid of Patients with Acute Ischemic Stroke
Hjalmarsson, C., Bjerke, M., Andersson, B., Blennow, K., Zetterberg, H., Åberg, N. D., Olsson, B., Eckerström, C., Bokemark, L., & Wallin, A. (2014) · Journal of Central Nervous System Disease · doi:10.4137/jcnsd.s13821 · Cited by 94
Self-citationJakobsson, J., Bjerke, M., Ekman, C. J., Sellgren, C. M., Johansson, A. G. M., Zetterberg, H., Blennow, K., & Landén, M. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.81 · Cited by 91
Self-citationPijnenburg, Y. A. L., Verwey, N. A., van der Flier, W. M., Scheltens, P., & Teunissen, C. E. (2015) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2015.11.001 · Cited by 91
Self-citationNeurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosis
Kühle, J., Malmeström, C., Axelsson, M., Plattner, K., Yaldizli, Ö., Derfuss, T. J., Giovannoni, G., Kappos, L., & Lycke, J. (2013) · Acta Neurologica Scandinavica · doi:10.1111/ane.12151 · Cited by 86
Self-citationCSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome
Khalil, M., Enzinger, C., Langkammer, C., Ropele, S., MADER, A., Trentini, A., Vane, M., Wallner-Blazek, M., Bachmaier, G., Archelos, J.-J., et al. (2012) · Multiple Sclerosis Journal · doi:10.1177/1352458512458010 · Cited by 86
Self-citationAssessing tissue damage in multiple sclerosis: a biomarker approach
Burman, J., Zetterberg, H., Fransson, M., Loskog, A., Raininko, R., & Fagius, J. (2014) · Acta Neurologica Scandinavica · doi:10.1111/ane.12239 · Cited by 85
Self-citationKhademi, M., Dring, A. M., Gilthorpe, J. D., Wuolikainen, A., Nimer, F. A., Harris, R. A., Andersson, M., Brundin, L., Piehl, F., Olsson, T. P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063172 · Cited by 85
Self-citationCSF neurofilament protein analysis in the differential diagnosis of ALS
Reijn, T. S., Abdo, W. F., Schelhaas, H. J., & Verbeek, M. M. (2009) · Journal of Neurology · doi:10.1007/s00415-009-0131-z · Cited by 80
Self-citationCSF Neurofilament Light Chain but not FLT3 Ligand Discriminates Parkinsonian Disorders
Herbert, M. K., Aerts, M. B., Beenes, M., Norgren, N., Esselink, R. A. J., Bloem, B. R., Kuiperij, H. B., & Verbeek, M. M. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00091 · Cited by 79
Self-citationStilund, M., Carstensen, M., Petersen, T., Møller, H. J., Rasmussen, P. V., & Christensen, T. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119681 · Cited by 76
Self-citationEikemo, T. A., Bambra, C. L., Huijts, T., & Fitzgerald, R. (2016) · European Sociological Review · doi:10.1093/esr/jcw019 · Cited by 75
Fruit and vegetable intake and cause-specific mortality in the EPIC study
Leenders, M. B., Boshuizen, H. C., Ferrari, P., Siersema, P. D., Overvad, K., Tjønneland, A. M., Olsen, A., Boutron‐Ruault, M., Dossus, L., Dartois, L., et al. (2014) · European Journal of Epidemiology · doi:10.1007/s10654-014-9945-9 · Cited by 74
Long-term trends of inequalities in mortality in 6 European countries
de Gelder, R., Menvielle, G., Costa, G., Kovács, K., Martikainen, P., Strand, B. H., & Mackenbach, J. P. (2016) · International Journal of Public Health · doi:10.1007/s00038-016-0922-9 · Cited by 69
Tortelli, R., Copetti, M., Ruggieri, M., Cortese, R., Capozzo, R., Leo, A., D’Errico, E., Mastrapasqua, M., Zoccolella, S., Pellegrini, F., et al. (2014) · European Journal of Neurology · doi:10.1111/ene.12421 · Cited by 67
Self-citationAeinehband, S., Lindblom, R. P. F., Nimer, F. A., Vijayaraghavan, S., Sandholm, K., Khademi, M., Olsson, T. P., Nilsson, B., Ekdahl, K. N., Darreh‐Shori, T., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122048 · Cited by 65
Self-citationWang, Y., Li, F. R., Wang, Z., Qiu, T., Shen, Y., & Wang, M. (2015) · Lung Cancer · doi:10.1016/j.lungcan.2015.02.015 · Cited by 64
Modvig, S., Degn, M., Horwitz, H., Cramer, S. P., Larsson, H. B. W., Wanscher, B., Sellebjerg, F. T., & Frederiksen, J. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077163 · Cited by 63
Self-citationSoylu-Kucharz, R., Sandelius, Å., Sjögren, M., Blennow, K., Wild, E. J., Zetterberg, H., & Björkqvist, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-14179-1 · Cited by 63
Self-citationPaterson, R. W., Toombs, J., Slattery, C. F., Nicholas, J. M., Andréasson, U., Magdalinou, N. K., Blennow, K., Warren, J. D., Mummery, C. J., Rossor, M. N., et al. (2015) · Journal of Neurology · doi:10.1007/s00415-015-7904-3 · Cited by 57
Self-citationCerebrospinal fluid neurofilament light chain levels predict visual outcome after optic neuritis
Modvig, S., Degn, M., Sander, B., Horwitz, H., Wanscher, B., Sellebjerg, F. T., & Frederiksen, J. L. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458515599074 · Cited by 55
Self-citationTrentini, A., Comabella, M., Tintoré, M., Koel‐Simmelink, M. J. A., Killestein, J., Roos, B., Rovira, À., Korth, C., Ottis, P., Blankenstein, M. A., et al. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7507-4 · Cited by 54
Self-citationCerebrospinal fluid immunological biomarkers associated with axonal damage in multiple sclerosis
Villar, L. M., Picón, C., Costa‐Frossard, L., Alenda, R., García‐Caldentey, J., Espiño, M., Muriel, A., & Álvarez‐Cermeño, J. C. (2014) · European Journal of Neurology · doi:10.1111/ene.12579 · Cited by 54
Self-citationVisser, P. J., Vos, S. J. B., van Rossum, I., & Scheltens, P. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.10.008 · Cited by 54
Self-citationHoffmann, R., Eikemo, T. A., Kulhánová, I., Kulik, M. C., Looman, C. W. N., Menvielle, G., Deboosere, P., Martikainen, P., Regidor, E., & Mackenbach, J. P. (2015) · European Journal of Public Health · doi:10.1093/eurpub/ckv090 · Cited by 54
Smoking and the potential for reduction of inequalities in mortality in Europe
Kulik, M. C., Hoffmann, R., Judge, K., Looman, C. W. N., Menvielle, G., Kulhánová, I., Toch-Marquardt, M., Östergren, O., Martikainen, P., Borrell, C., et al. (2013) · European Journal of Epidemiology · doi:10.1007/s10654-013-9860-5 · Cited by 53
Rolstad, S., Jakobsson, J., Sellgren, C. M., Ekman, C. J., Blennow, K., Zetterberg, H., Pålsson, E., & Landén, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127100 · Cited by 52
Self-citationGonzález, R., Heaton, R. K., Moore, D. J., Letendre, S. L., Ellis, R. J., Wolfson, T. J., Marcotte, T. D., Cherner, M., Rippeth, J. D., Grant, I., et al. (2003) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617703910071 · Cited by 51
Vitamin D and axonal injury in multiple sclerosis
Sandberg, L., Biström, M., Salzer, J., Vågberg, M., Svenningsson, A., & Sundström, P. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458515606986 · Cited by 49
Self-citationHoffmann, R., Eikemo, T. A., Kulhánová, I., Dahl, E. S., Deboosere, P., Dzúrová, D., Oyen, H. J. V., Rychtaříková, J., Strand, B. H., & Mackenbach, J. P. (2012) · Journal of Epidemiology & Community Health · doi:10.1136/jech-2011-200886 · Cited by 47
Plassman, B. L., Khachaturian, A. S., Townsend, J. J., Ball, M. J., Steffens, D. C., Leslie, C., Tschanz, J. T., Norton, M. C., Burke, J. R., Welsh-Bohmer, K. A., et al. (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2005.11.001 · Cited by 46
Bruno, D., Pomara, N., Nierenberg, J. J., Ritchie, J., Lutz, M. W., Zetterberg, H., & Blennow, K. (2011) · Experimental Gerontology · doi:10.1016/j.exger.2011.09.008 · Cited by 40
Self-citationPérez‐Santiago, J., Schrier, R. D., Oliveira, M. F., Gianella, S., Var, S. R., Day, T. R. C., Ramirez-Gaona, M., Suben, J. D., Murrell, B., Massanella, M., et al. (2015) · Journal of NeuroVirology · doi:10.1007/s13365-015-0384-5 · Cited by 39
Self-citationHu, X., Yan, Y., & Gong, D. (2016) · Neurological Sciences · doi:10.1007/s10072-016-2783-7 · Cited by 37
Bjerke, M., Jonsson, M. A. G., Nordlund, A., Eckerström, C., Blennow, K., Zetterberg, H., Pantoni, L., Inzitari, D., Schmidt, R., & Wallin, A. (2014) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000366119 · Cited by 32
Self-citationCerebrospinal fluid biomarkers in cardiac arrest survivors
Rosén, C., Rosén, H., Andréasson, U., Bremell, D., Bremler, R., Hagberg, L., Rosengren, L., Blennow, K., & Zetterberg, H. (2013) · Resuscitation · doi:10.1016/j.resuscitation.2013.10.032 · Cited by 32
Self-citationLuo, S. Y., Li, Y., Luo, H. L., Yin, X. H., Lin, D. R., Zhao, K., Huang, G. L., & Song, J. K. (2016) · Scientific Reports · doi:10.1038/srep19783 · Cited by 29
(2005) · Neurosurgery · doi:10.1093/neurosurgery/57.3.n4 · Cited by 26
Fialová, L., Bartoš, A., Švarcová, J., Zimová, D., & Kotoucova, J. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.03.009 · Cited by 25
Self-citationLow cerebrospinal fluid sulfatide predicts progression of white matter lesions: The LADIS study
Jonsson, M., Zetterberg, H., Rolstad, S., Edman, A., Gouw, A. A., Bjerke, M., Lind, K., Blennow, K., Pantoni, L., Inzitari, D., et al. (2012) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000341576 · Cited by 22
Self-citationNon-neurological surgery and cerebrospinal fluid biomarkers for neuronal and astroglial integrity
Anckarsäter, R., Anckarsäter, H. S., Bromander, S., Blennow, K., Wass, C., & Zetterberg, H. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-013-1156-0 · Cited by 21
Self-citationTortorella, C., Direnzo, V., Taurisano, P., Romano, R., Ruggieri, M., Zoccolella, S., Mastrapasqua, M., Popolizio, T., Blasi, G., Bertolino, A., et al. (2014) · Multiple Sclerosis Journal · doi:10.1177/1352458514546789 · Cited by 19
Self-citationGiovannoni, G., & Nath, A. (2011) · Neurology · doi:10.1212/wnl.0b013e3182143345 · Cited by 19
Neurofilaments and tau proteins in cerebrospinal fluid and serum in dementias and neuroinflammation
Fialová, L., Bartoš, A., & Švarcová, J. (2017) · Biomedical Papers · doi:10.5507/bp.2017.038 · Cited by 16
Self-citationImpact of Question Wording on the Measurement of Activity Limitation
Cambois, E., Grobon, S., Oyen, H. J. V., et al. (2016) · Journal of Aging and Health · doi:10.1177/0898264316656504 · Cited by 11
A Comparison of Two Methods of Measuring Food Group Intake: Grams vs Servings
Nöthlings, U., Murphy, S. P., Sharma, S., et al. (2006) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2006.02.006 · Cited by 10
Ragnarsson, Ó., Berglund, P., Eder, D. N., Zetterberg, H., Hietala, M. A., Blennow, K., & Johannsson, G. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0205 · Cited by 7
Self-citation
Research works printed but not linked: 2
- Vandenbroucke, 2007, 18, 805
- Tortorella, Cerebrospinal fluid neurofilament light levels mark grey matter volume in clinically isolated syndrome suggestive of multiple sclerosis [published correction appears in Mult Scler. 2019;25(2):302]., Mult Scler J
Cited by
Sorted by citations
Scheltens, P., De Strooper, B., Kivipelto, M., Holstege, H., Chételat, G., Teunissen, C. E., Cummings, J., & van der Flier, W. M. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32205-4 · Cited by 5,465
Self-citationAlzheimer Disease: An Update on Pathobiology and Treatment Strategies
Long, J. M., & Holtzman, D. M. (2019) · Cell · doi:10.1016/j.cell.2019.09.001 · Cited by 3,204
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
Jack, C. R., Andrews, J. S., Beach, T. G., Buracchio, T., Dunn, B., Graf, A., Hansson, O., Ho, C., Jagust, W., McDade, E., et al. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.13859 · Cited by 2,803
Self-citationBlood-based biomarkers for Alzheimer's disease: towards clinical implementation
Teunissen, C. E., Verberk, I. M. W., Thijssen, E. H., Vermunt, L., Hansson, O., Zetterberg, H., van der Flier, W. M., Mielke, M. M., & del Campo, M. (2022) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00361-6 · Cited by 1,045
Self-citationAdvancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL) investigators, Thijssen, E. H., La Joie, R., Wolf, A., Strom, A., Wang, P., Iaccarino, L., Bourakova, V., Cobigo, Y., Heuer, H., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0762-2 · Cited by 761
Self-citation
Metadata
- Authors
- Bridel, C., van Wieringen, W. N., Zetterberg, H., Tijms, B. M., Teunissen, C. E., and the NFL Group, Alvarez-Cermeño, J. C., Andreasson, U., Axelsson, M., Bäckström, D. C., Bartos, A., Bjerke, M., Blennow, K., Boxer, A., Brundin, L., Burman, J., Christensen, T., Fialová, L., Forsgren, L., Frederiksen, J. L., Gisslén, M., Gray, E., Gunnarsson, M., Hall, S., Hansson, O., Herbert, M. K., Jakobsson, J., Jessen-Krut, J., Janelidze, S., Johannsson, G., Jonsson, M., Kappos, L., Khademi, M., Khalil, M., Kuhle, J., Landén, M., Leinonen, V., Logroscino, G., Lu, C.-H., Lycke, J., Magdalinou, N. K., Malaspina, A., Mattsson, N., Meeter, L. H., Mehta, S. R., Modvig, S., Olsson, T., Paterson, R. W., Pérez-Santiago, J., Piehl, F., Pijnenburg, Y. A. L., Pyykkö, O. T., Ragnarsson, O., Rojas, J. C., Romme Christensen, J., Sandberg, L., Scherling, C. S., Schott, J. M., Sellebjerg, F. T., Simone, I. L., Skillbäck, T., Stilund, M., Sundström, P., Svenningsson, A., Tortelli, R., Tortorella, C., Trentini, A., Troiano, M., Turner, M. R., van Swieten, J. C., Vågberg, M., Verbeek, M. M., Villar, L. M., Visser, P. J., Wallin, A., Weiss, A., Wikkelsø, C., & Wild, E. J.
- Affiliations
- Amsterdam Neuroscience (NL)
- Department of Epidemiology and Biostatistics, VU University Medical Centre, Amsterdam, the Netherlands
- Sahlgrenska University Hospital (SE)
- Hospital Universitario Ramón y Cajal (ES)
- Multiple Sclerosis Unit, Ramon y Cajal University Hospital, Madrid, Spain
- Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden
- University of Gothenburg (SE)
- Charles University (CZ)
- Third Faculty of Medicine, Department of Neurology, Charles University and General University Hospital, Prague, Czech Republic
- University of Antwerp (BE)
- University of California, San Francisco (US)
- Karolinska University Hospital (SE)
- Uppsala University (SE)
- Aarhus University (DK)
- Copenhagen University Hospital (DK)
- University of Oxford (GB)
- Lund University (SE)
- University of Basel (CH)
- Department of Medicine, University Hospital and University of Basel, Basel, Switzerland
- University of Eastern Finland (FI)
- China Medical University Hospital (TW)
- National Hospital for Neurology and Neurosurgery (GB)
- Queen Mary University of London (GB)
- Erasmus MC (NL)
- University of Puerto Rico, Medical Sciences Campus (PR)
- Puerto Rico OMICS Centre, University of Puerto Rico Comprehensive Cancer Centre, San Juan
- Department of Neurology, Faculty of Medicine and Health, Orebro University Hospital, Orebro, Sweden
- Department of Neurology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
- Belmont University (US)
- Azienda Ospedaliera San Camillo-Forlanini (IT)
- Danderyds sjukhus (SE)
- Pia Fondazione di Culto e Religione Azienda Ospedaliera "Card. G. Panico" (IT)
- University of Ferrara (IT)
- Alzheimer Centre and Department of Neurology, Erasmus Medical Centre, Rotterdam, the Netherlands
- Radboud University Nijmegen (NL)
- Maastricht University (NL)
- Evotec (Germany) (DE)
- Corresponding author
- Bridel, Claire
- ORCID
- Bridel, Claire
- Zetterberg, Henrik
- Tijms, Betty M.
- Teunissen, Charlotte E.
- Axelsson, Markus
- Bäckström, David C.
- Bjerke, Maria
- Blennow, Kaj
- Boxer, Adam
- Brundin, Lou
- Burman, Joachim
- Christensen, Tove
- Fialová, Lenká
- Forsgren, Lars
- Frederiksen, Jette L.
- Gisslén, Magnus
- Gray, Elizabeth
- Hall, Sara
- Hansson, Oskar
- Herbert, Megan K.
- Jakobsson, Joel
- Janelidze, Shorena
- Johannsson, Gudmundur
- Jonsson, Michael
- Kappos, Ludwig
- Khademi, Mohsen
- Khalil, Michael
- Landén, Mikael
- Leinonen, Ville
- Logroscino, Giancarlo
- Lu, Ching-Hua
- Lycke, Jan
- Malaspina, Andrea
- Mattsson, Niklas
- Meeter, Lieke H.
- Mehta, Sanjay R.
- Modvig, Signe
- Olsson, Tomas
- Paterson, Ross W.
- Piehl, Fredrik
- Pijnenburg, Yolande A. L.
- Rojas, Julio C.
- Schott, Jonathan M.
- Sellebjerg, Finn T.
- Simone, Isabella L.
- Skillbäck, Tobias
- Stilund, Morten
- Sundström, Peter
- Svenningsson, Anders
- Tortelli, Rosanna
- Tortorella, Carla
- Trentini, Alessandro
- Turner, Martin R.
- Vågberg, Mattias
- Verbeek, Marcel M.
- Villar, Luisa M.
- Visser, Pieter Jelle
- Wallin, Anders
- Weiss, Andreas
- Wikkelsø, Carsten
- Wild, Edward J.
- Venue
- JAMA Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2019-09-01
- Volume
- 76
- Issue
- 9
- Pages
- 1035
- ISSN
- 2168-6149 (ISSN-L)
- PMC
- PMC6580449
- OpenAlex
- W2950228559
- Cited by
- 764
- References
- 107
- Citations by year
- 2026: 76 · 2025: 116 · 2024: 115 · 2023: 105 · 2022: 119 · 2021: 108 · 2020: 102 · 2019: 21
- FWCI
- 65.69
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA Neurology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, other-oa)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- UCL Discovery (University College London) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion, other-oa)
- Radboud Repository (Radboud University) (submittedVersion)
- CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) (submittedVersion, other-oa)
- Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion, other-oa)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- Eli Lilly and Company
- AstraZeneca
- Bayer
- Sanofi
- Biogen
- CHDI Foundation
- Teva Pharmaceutical Industries
- Itä-Suomen Yliopisto
- Universität Basel
- European Committee for Treatment and Research in Multiple Sclerosis
- EU Joint Programme – Neurodegenerative Disease Research
- European Federation of Pharmaceutical Industries and Associations (115372)
- European Huntington's Disease Network
- National Institute for Health and Care Research (CL-2016-18-004)
- Motor Neurone Disease Association (TURNER/OCT18/989-797, MALASPINA/APR13/817-791, MR/ K01014X/1, TURNER/OCT15/972-797)
- European Commission (HORIZON2020, 733050202, 115372, 633666)
- Bayer HealthCare
- National Research Foundation
- ZonMw (733050202, 733050822, 733050824)
- Radboud Universiteit
- Vrije Universiteit Amsterdam
- Universiteit Maastricht
- Gentofte Hospital
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (733050822)
- Karolinska Institutet
- Kuopion Yliopistollinen Sairaala
- China Medical University Hospital
- Sahlgrenska Universitetssjukhuset
- Università degli Studi di Ferrara
- China Medical University
- Red Española de Esclerosis Múltiple
- Karl-Franzens-Universität Graz
- Novo Nordisk Fonden (NNF17OC0026978)
- Medizinische Universität Graz
- Stichting Dioraphte
- Alzheimer Nederland
- H. Lundbeck A/S
- Barts Health NHS Trust
- Janssen Prevention Center
- Allergan
- University of California, San Diego
- Avid Radiopharmaceuticals
- Medical Research Council (MR/K01014X/1, MR/M008592/1)
- Economic and Social Research Council (ES/K000365/1)
- Instituto de Salud Carlos III
- National Institute on Aging (K23AG059888, P01AG019724, T32AG023481)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Clinical Neurology › Cerebrospinal fluid and hydrocephalus
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- neurofilament light chain, cerebrospinal fluid biomarkers, neuroaxonal damage, age and sex effects, differential diagnosis, frontotemporal dementia, HIV-associated neurocognitive disorders, amyotrophic lateral sclerosis, Huntington's disease, Alzheimer's disease, Parkinson's disease, multiple sclerosis, dementia, neuroinflammation, diagnostic accuracy, neurodegeneration
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
